Status:

RECRUITING

Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity

Lead Sponsor:

John Bauer

Conditions:

Obesity and Overweight

Obese Adolescents

Eligibility:

All Genders

12-17 years

Brief Summary

The goal of this clinical trial is to learn if the drug semaglutide changes markers of disease risk as it relates to weight in children ages 12-15 years old who are obese (class 2 or 3). The main ques...

Detailed Description

This is an observational study in which all participants will be given semaglutide. There will be no randomization and no placebo. Participants will be in the study for 12 months (+/- 2 months) depen...

Eligibility Criteria

Inclusion

  • Patient seen at University of Kentucky Pediatric High BMI Clinic
  • Diagnosis of Obesity Class 2 or 3
  • Meeting the clinical criteria for the medical intervention with semaglutide for weight loss

Exclusion

  • Any current prescribed anti-obesity medications (AOM) such as Orlistat, Phentermine, Qsymia (Phentermine/Topiramate), Liraglutide, Semaglutide, and Setmelanotide
  • Any current prescribed anti-hypertensive medications
  • Any specific end-organ acute concerns (kidney disease, liver disease, congenital disease).
  • Any active infections at enrollment.
  • Any systemic steroid use longer than 3 month use or within the last month before enrollment (not including inhaled, ophthalmic, intranasal, and topical).
  • Any limitations that would make exercise testing not possible.
  • Any congenital abnormality or genetic syndrome known to be associated with obesity
  • Pregnancy
  • Inability to receive an MRI
  • Personal or family history of medullary thyroid carcinoma (per product insert)
  • Patients with Multiple Endocrine Neoplasia syndrome type 2 (per product insert)

Key Trial Info

Start Date :

June 12 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2027

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06967389

Start Date

June 12 2025

End Date

July 1 2027

Last Update

July 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Kentucky

Lexington, Kentucky, United States, 40506